Patients presumed “cured” from long Covid and who instead after many weeks still have difficulty breathing: a circulatory defect of the pulmonary capillaries was discovered in 60% of the subjects examined, a residue of the covid, responsible for the continuous dyspnoea. The novelty demonstrated thanks to a two-year study, the first in the world, presented in Taormina at the XV Pneumomeeting by Roberto W. Dal Negro, director of the Specialist Medical Center of Verona, who published it in the international scientific literature in recent weeks. «We have identified it through very advanced equipment, there are few in Italy and it is not visible in any other way, for example CT scans are useless. On December 6th at the national congress of Cardiology – he announced – I will deepen the topic by also talking about nebivolol, an old molecule (already used for pulmonary hypertension, ed) potentially effective against the effects of long covid and subject to a further published a few days ago.
Many topics were discussed at the Taormina congress, now in its 15th edition, by over 200 pulmonologists who appealed to the new regional councilor for health, Giovanna Volo: to lighten hospitals from the burden of some particularly widespread respiratory pathologies such as asthma or lung and lung diseases, typical of smokers, who can be treated in the area and invest in specialist figures, still lacking.
“We need to focus on peripheral structures – explained Salvatore Privitera, director of the Giarre Respiratory Insufficiency Center – they are closer and more comfortable for the patient who has a continuous need to consult a specialist without increasing hospital management and assistance costs, when it is not necessary hospitalization”. A round table on the critical issues that emerged during the pandemic: “Pneumonology played a leading role in the pandemic phase – underlined Salvatore Bellofiore – head of the San Marco Polyclinic Pulmonology Ambulatory in Catania – we worked closely with infectious disease specialists and resuscitators”.
For Giovanni Passalacqua director of respiratory diseases of the Papardo of Messina “We must not let our guard down because we are not in the post-covid phase but in a new phase of the pandemic”. According to the pulmonologist of the Asp of Catania Riccardo Giuliano: “It is essential to plan health care with more foresight and not in the short term, to overcome the disparities and inconsistencies in Sicily”. The spotlight is turned on the “big killer” lung cancer which in Italy has 41 thousand new cases every year and 34 thousand deaths and in Sicily, the third region by number of smokers, 3 thousand diagnoses of which two thirds are men and on interstitial lung diseases: ” They affect precisely the area of the organ where oxygen is absorbed – highlighted Carlo Vancheri, full professor of respiratory diseases at the University of Catania and president of the Italian Society of Pneumology – we are studying new very interesting therapeutic perspectives”.
Before the congress, a meeting between specialists and Antonio Colucci, representing the regional councillorship: «We explained what the accreditation criteria must be by the Asp and health structures – said Mario Schisano, pulmonologist former medical director of Asp Syracuse – at order to activate the home care procedure for all respiratory pathologies, in particular respiratory insufficiency”. Focus also on hospital infections, chronic cough, chronic respiratory insufficiency, respiratory physiopathology, pulmonary ventilation with illustrious speakers from all over Italy, including Erino Rendina, pioneering trachea transplant surgeon, who spoke about tracheobronchopulmonary surgical pathology after Covid.
© Reproduction reserved